NeuroPace (NPCE) Net Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -296.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 656.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -430.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | -67.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67.00 |
| Dec 31, 2025 | 1,379.00 |
| Sep 30, 2025 | 1,385.00 |
| Jun 30, 2025 | 493.00 |
| Mar 31, 2025 | 2,064.00 |
| Dec 31, 2024 | 1,184.00 |
| Sep 30, 2024 | 1,795.00 |
| Jun 30, 2024 | 1,636.00 |
| Mar 31, 2024 | 1,652.00 |
| Dec 31, 2023 | 5,012.00 |
| Sep 30, 2023 | 5,983.00 |
| Jun 30, 2023 | 6,758.00 |
| Mar 31, 2023 | 3,469.00 |
| Dec 31, 2022 | 1,121.00 |
| Sep 30, 2022 | -2,798.00 |
| Jun 30, 2022 | -7,308.00 |
| Mar 31, 2022 | -4,995.00 |
| Dec 31, 2021 | -5,198.00 |
| Sep 30, 2021 | -4,574.00 |
| Jun 30, 2021 | 4,451.00 |
| Mar 31, 2021 | 3,398.00 |